110 related articles for article (PubMed ID: 16720309)
1. Real-time contrast-enhanced specific ultrasound in staging and follow-up of splenic lymphomas.
Tafuto S; Catalano O; Barba G; Sandomenico F; Lobianco R; Tortoriello A; Formato R; Comella P; Siani A; Di Meo M; Iaffaioli RV; Quattrin S
Front Biosci; 2006 Sep; 11():2224-9. PubMed ID: 16720309
[TBL] [Abstract][Full Text] [Related]
2. Real-time contrast-enhanced ultrasound of the spleen: examination technique and preliminary clinical experience.
Catalano O; Lobianco R; Sandomenico F; D'Elia G; Siani A
Radiol Med; 2003 Oct; 106(4):338-56. PubMed ID: 14612826
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasonography with SonoVue: differentiation between benign and malignant lesions of the spleen.
von Herbay A; Barreiros AP; Ignee A; Westendorff J; Gregor M; Galle PR; Dietrich C
J Ultrasound Med; 2009 Apr; 28(4):421-34. PubMed ID: 19321670
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of benign from malignant focal splenic lesions using sulfur hexafluoride-filled microbubble contrast-enhanced pulse-inversion sonography.
Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Malzfeldt E; Braumann D
AJR Am J Roentgenol; 2009 Sep; 193(3):709-21. PubMed ID: 19696284
[TBL] [Abstract][Full Text] [Related]
5. [Feasability of real time contrast enhanced ultrasound in renal disease].
Tranquart F; Correas JM; Martegani A; Greppi B; Bokor D
J Radiol; 2004 Jan; 85(1):31-6. PubMed ID: 15094637
[TBL] [Abstract][Full Text] [Related]
6. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
7. Splenic metastases in gynaecologic cancer: clinical considerations, US, and CT diagnostic results.
La Fianza A; Madonia L
Radiol Med; 2003; 106(1-2):36-43. PubMed ID: 12951549
[TBL] [Abstract][Full Text] [Related]
8. Contrast enhanced sonography of focal splenic lesions with a second-generation contrast agent.
Görg C; Bert T
Ultraschall Med; 2005 Dec; 26(6):470-7. PubMed ID: 16453218
[TBL] [Abstract][Full Text] [Related]
9. Contrast enhanced ultrasound with second generation contrast agent in traumatic liver lesions.
Miele V; Buffa V; Stasolla A; Regine G; Atzori M; Ialongo P; Adami L
Radiol Med; 2004; 108(1-2):82-91. PubMed ID: 15269692
[TBL] [Abstract][Full Text] [Related]
10. Incidentally detected splenic lesions in ultrasound: does contrast-enhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions?
Stang A; Keles H; Hentschke S; von Seydewitz CU; Dahlke J; Habermann C; Wessling J
Ultraschall Med; 2011 Dec; 32(6):582-92. PubMed ID: 22161555
[TBL] [Abstract][Full Text] [Related]
11. The forgotten organ: contrast enhanced sonography of the spleen.
Görg C
Eur J Radiol; 2007 Nov; 64(2):189-201. PubMed ID: 17920224
[TBL] [Abstract][Full Text] [Related]
12. [Ultrasound involvement of the spleen in non-Hodgkin's lymphomas].
Görg C; Weide R; Schwerk WB
Ultraschall Med; 1995 Jun; 16(3):104-8. PubMed ID: 7667616
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.
Ooi CC; Low SC; Schneider-Kolsky M; Lombardo P; Lim SY; Abu Bakar R; Lo RH
J Med Imaging Radiat Oncol; 2010 Oct; 54(5):421-30. PubMed ID: 20958940
[TBL] [Abstract][Full Text] [Related]
14. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?
Leen E; Ceccotti P; Moug SJ; Glen P; MacQuarrie J; Angerson WJ; Albrecht T; Hohmann J; Oldenburg A; Ritz JP; Horgan PG
Ann Surg; 2006 Feb; 243(2):236-40. PubMed ID: 16432357
[TBL] [Abstract][Full Text] [Related]
15. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI.
Meloni MF; Bertolotto M; Alberzoni C; Lazzaroni S; Filice C; Livraghi T; Ferraioli G
AJR Am J Roentgenol; 2008 Oct; 191(4):1233-8. PubMed ID: 18806170
[TBL] [Abstract][Full Text] [Related]
16. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
17. Off-Label Use of Ultrasound Contrast Agents for Intravenous Applications in Children: Analysis of the Existing Literature.
Rosado E; Riccabona M
J Ultrasound Med; 2016 Mar; 35(3):487-96. PubMed ID: 26839372
[TBL] [Abstract][Full Text] [Related]
18. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of magnetic resonance imaging in lymphoma staging.
Skillings JR; Bramwell V; Nicholson RL; Prato FS; Wells G
Cancer; 1991 Apr; 67(7):1838-43. PubMed ID: 2004296
[TBL] [Abstract][Full Text] [Related]
20. Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.
Vinnicombe SJ; Reznek RH
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S42-55. PubMed ID: 12709830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
